Repositorio Digital

A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial

Mostrar el registro sencillo del ítem

dc.contributor.author Vinereanu, Dragos
dc.contributor.author Lopes, Renato
dc.contributor.author Bahit, Cecilia
dc.contributor.author Xavier, Denis
dc.contributor.author Jiang, Jie
dc.contributor.author Al-Khalidi, Hussein R
dc.contributor.author He, Wensheng
dc.contributor.author Xian, Ying
dc.contributor.author Ciobanu, Andrea O
dc.contributor.author Kamath, Deepak Y
dc.contributor.author Fox, Kathleen A
dc.contributor.author Rao, Meena P
dc.contributor.author Pokorney, Sean D
dc.contributor.author Berwanger, Otavio
dc.contributor.author Tajer, Carlos
dc.contributor.author de Barros e Silva, Pedro
dc.contributor.author Roettig, Mayme L
dc.contributor.author Huo, Yong
dc.contributor.author Granger, Christopher B
dc.contributor.author Carbajales, Justo
dc.contributor.author Gómez, Javier Neri Ceferino
dc.contributor.author Principato, Mario Bruno
dc.contributor.author Von Wulffen, María Alejandra
dc.contributor.author Acunzo, Jorge Galperín Rafael Salvador
dc.contributor.author Bonato, Ricardo Renato
dc.contributor.author Ciampi, Natalia
dc.contributor.author Marani, Alberto Babil
dc.contributor.author Panigadi, Cristian Gustavo
dc.contributor.author Pastura, Silvia Gabriela
dc.contributor.author Onetto, Leonardo Martín
dc.contributor.author IMPACT-AF investigators
dc.date.accessioned 2019-03-12T18:42:22Z
dc.date.available 2019-03-12T18:42:22Z
dc.date.issued 2017
dc.identifier.issn 0140-6736
dc.identifier.other 10.1016/S0140-6736(17)32165-7
dc.identifier.uri http://repositorio.hospitalelcruce.org/xmlui/handle/123456789/769
dc.description Fil: Tajer, C. Hospital de Alta Complejidad en Red El Cruce Dr. Néstor C. Kirchner. Servicio de Cardiología. Florencio Varela, Argentina. es_AR
dc.description.abstract BACKGROUND: Oral anticoagulation is underused in patients with atrial fibrillation. We assessed the impact of a multifaceted educational intervention, versus usual care, on oral anticoagulant use in patients with atrial fibrillation. METHODS: This study was a two-arm, prospective, international, cluster-randomised, controlled trial. Patients were included who had atrial fibrillation and an indication for oral anticoagulation. Clusters were randomised (1:1) to receive a quality improvement educational intervention (intervention group) or usual care (control group). Randomisation was carried out centrally, using the eClinicalOS electronic data capture system. The intervention involved education of providers and patients, with regular monitoring and feedback. The primary outcome was the change in the proportion of patients treated with oral anticoagulants from baseline assessment to evaluation at 1 year. The trial is registered at ClinicalTrials.gov, number NCT02082548. FINDINGS: 2281 patients from five countries (Argentina, n=343; Brazil, n=360; China, n=586; India, n=493; and Romania, n=499) were enrolled from 48 clusters between June 11, 2014, and Nov 13, 2016. Follow-up was at a median of 12·0 months (IQR 11·8-12·2). Oral anticoagulant use increased in the intervention group from 68% (804 of 1184 patients) at baseline to 80% (943 of 1184 patients) at 1 year (difference 12%), whereas in the control group it increased from 64% (703 of 1092 patients) at baseline to 67% (732 of 1092 patients) at 1 year (difference 3%). Absolute difference in the change between groups was 9·1% (95% CI 3·8-14·4); odds ratio of change in the use of oral anticoagulation between groups was 3·28 (95% CI 1·67-6·44; adjusted p value=0·0002). Kaplan-Meier estimates showed a reduction in the secondary outcome of stroke in the intervention versus control groups (HR 0·48, 95% CI 0·23-0·99; log-rank p value=0·0434). INTERPRETATION: A multifaceted and multilevel educational intervention, aimed to improve use of oral anticoagulation in patients with atrial fibrillation and at risk for stroke, resulted in a significant increase in the proportion of patients treated with oral anticoagulants. Such an intervention has the potential to improve stroke prevention around the world for patients with atrial fibrillation. es_AR
dc.description.sponsorship FUNDING: Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, and Pfizer. es_AR
dc.language.iso en_US es_AR
dc.subject Estudios Clínicos como Asunto es_AR
dc.subject Análisis por Conglomerados es_AR
dc.subject Fibrilación Atrial es_AR
dc.subject Arritmias Cardíacas es_AR
dc.subject Anticoagulantes es_AR
dc.title A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial es_AR
dc.type Article es_AR


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem